Related Experiment Video

Updated: Jul 13, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide

Anna D Petropoulou1, Grigoris T Gerotziafas, Meyer M Samama

  • 1Service d'Hématologie Biologique, Hôpital Hôtel-Dieu, Assistance Publique Hôpitaux de Paris, France. annakyla@hotmail.com

Thrombosis Research
|July 10, 2007
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Related Experiment Videos

Last Updated: Jul 13, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Articles linked to this work by shared authors, journal, and citation graph.

Combined Oral Contraceptives and the Risk of Thrombosis.

International journal of molecular sciences·2025

Safety and effectiveness of apixaban use for stroke prevention during Ramadan fasting (the API-RAM study).

Frontiers in pharmacology·2025

Corrigendum: Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives.

TH open : companion journal to thrombosis and haemostasis·2025

Systemic Inflammatory Response Syndrome, Thromboinflammation, and Septic Shock in Fetuses and Neonates.

International journal of molecular sciences·2025

Cerebral vein thrombosis: management tactics with a focus on pregnancy, the use of hormone therapy and assisted reproductive technologies.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2025

The Phenomenon of Thrombotic Microangiopathy in Cancer Patients.

International journal of molecular sciences·2024

Clinical and molecular characteristics of hereditary factor XII deficiency in Chinese Han patients: Novel mutations, a high-frequency frameshift variant, and plasma metabolomic profiling.

Thrombosis research·2026

Distinct coagulation-fibrinolysis profiles in traumatic and upper gastrointestinal hemorrhagic shock: Clinical relevance of tPA/PAI-1 complex in traumatic hemorrhagic shock.

Thrombosis research·2026

Substitution-induced allosteric activation of coagulation factor IX as a potential alternative hemophilia A treatment strategy.

Thrombosis research·2026

Development and external validation of a text-matching algorithm to identify patients with lower extremity deep venous thrombosis from radiology reports at five medical centers.

Thrombosis research·2026

Predicting chronic immune thrombocytopenia in children using IFNA17 rs9298814 polymorphism and clinical features: a study from a low- and middle-income country.

Thrombosis research·2026

Long-term analytical performance of apixaban measurements based on external quality assessment data.

Thrombosis research·2026

Image-Guided Thyroid Ablation versus Surgery for T1N0M0 Papillary Thyroid Carcinoma: A Consensus-Aligned Systematic Review and Meta-Analysis.

Balkan medical journal·2026

Urachal inflammatory myofibroblastic tumor: a case report.

Frontiers in oncology·2026

Cytologic Features of Inflammatory Rhabdomyoblastic Tumor Using Conventional and Liquid-Based Cytology Preparations: A Case Report.

Diagnostic cytopathology·2026

Tumor-infiltrating B cells evolve towards interferon-rich trajectories aligned with immunotherapy in melanoma.

Journal of experimental & clinical cancer research : CR·2026

Acute development of EBV+ T-cell lymphoproliferative disorder after treatment with rituximab for follicular lymphoma.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026

Thymosin α-1 in Cancer Therapy: Immunomodulatory Mechanisms, Clinical Applications, and Translational Perspectives.

European journal of pharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us